NEW YORK (GenomeWeb News) – The National Institutes of Health plans to fund studies aimed at validating genomic and other types of biomarkers for human diseases that affect the liver, kidney, urological tract, digestive and hematologic systems, and endocrine and metabolic disorders, according to a new funding announcement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

In Nature this week: a Danish reference genome, and more.